Abstracts tagged "Gynecologic issues"

Abstract Number: 573 • 2017 ACR/ARHP Annual Meeting
Subepithelial Infiltrate of the Vagina in Primary Sjogren’s Syndrome: The Cause of Vaginal Dryness?
Jolien F. van Nimwegen¹, Karin van der Tuuk², Ellen R. Klinkert², Erlin A. Haacke³, Frans G.M. Kroese¹, Harry Hollema³, Marian J. Mourits² and Hendrika Bootsma¹, ¹Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ²Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ³Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
Background/Purpose: Women with primary Sjögren’s syndrome (pSS) often experience vaginal dryness. The cause of this symptom is unknown. This study compared the vaginal and cervical…
Abstract Number: 1318 • 2017 ACR/ARHP Annual Meeting
Abnormal Cerviovaginal Cytology in Adolescents with Systemic Lupus Erythematosus: A Retrospective Case Series
Jennifer Kurkowski¹, Martha Curry², Marietta deGuzman³, Jane Geyer⁴ and Oluyemisi Adeyemi-Fowode⁵, ¹Department of Obstetrics and Gynecology, Baylor College of Medicine, Texas Childrens Hospital, Houston, TX, ²Pediatric rheumatology, Baylor College of Medicine and Texas Childrens Hospital, Houston, TX, ³Baylor College of Medicine, Division of Pediatric Rheumatology, Houston, TX, ⁴Baylor College of Medicine, Division of Pediatric and Adolescent Gynecology, Houston, TX, ⁵Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Childrens Hospital, Houston, TX
Background/Purpose: Guidelines recommend screening for cervical cancer in women starting at age 21 but according to the American Congress of Obstetricians and Gynecologists, exceptions should…
Abstract Number: 2835 • 2013 ACR/ARHP Annual Meeting
Safety Of Gardasil® Vaccine In Systemic Lupus Erythematosus
J. Patricia Dhar¹, Lynnette Essenmacher², Renee Dhar³, Ardella Magee⁴, Joel Ager⁵, Malini Venkatram¹, Harpreet Sagar¹ and Robert Sokol⁶, ¹Internal Medicine/Rheumatology, Wayne State University, Detroit, MI, ²Wayne State University, Detroit, MI, ³Department of Clinical and Translational Research, Wayne State University, Detroit, MI, ⁴Clinical Research Center, Wayne State University, Detroit, MI, ⁵Family Medicine Department, Wayne State University, Detroit, MI, ⁶Obstetrics and Gynecology, Wayne State University, Detroit, MI
Background/Purpose: Cervical neoplasia is increased in women with SLE presumably due to cervical infection with oncogenic Human Papillomavirus (HPV) types which persist in an immunosuppressed…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].